Bayesian Capital Management’s Claritev Corp CTEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-343
Closed -$39K 1075
2022
Q3
$39K Sell
343
-230
-40% -$38K 0.01% 633
2022
Q2
$126K Buy
+573
New +$113K 0.02% 666
2022
Q1
Sell
-903
Closed -$160K 955
2021
Q4
$160K Buy
+903
New +$161K 0.05% 329

Other funds holding CTEV

Bayesian Capital Management's CTEV Position: Q4 2022 in Review

Bayesian Capital Management sold out of Claritev Corp (CTEV) in Q4 2022, closing a stake of 343 shares — an estimated $39K sold.

Bayesian Capital Management first reported a position in CTEV in Q4 2021 and held it in 3 quarters. The position peaked at $160K in Q4 2021. 130 funds tracked by Wall St. Rank hold CTEV as of Q4 2022.

  • Bayesian Capital Management reported no remaining Claritev Corp position as of Q4 2022 after selling out during the quarter.
  • Bayesian Capital Management sold 343 Claritev Corp shares in Q4 2022, an estimated $39K.
  • Bayesian Capital Management first reported a position in Claritev Corp in Q4 2021 and held it in 3 quarters.
  • Bayesian Capital Management's Claritev Corp position peaked at $160K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Claritev Corp as of Q4 2022.

Based on Bayesian Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.